Proteus 235 Proton Therapy System for cancer treatment.
Published November 5, 2014 · Recall initiated: March 27, 2014
Summary
FDA records medical device Class II recall Z-0020-2015, published November 5, 2014 and initiated March 27, 2014. Recalling firm: Ion Beam Applications S.A.; Status: Terminated; Reported quantity: 8; Lot: PAT.107, PAT.109, PAT.112, PAT.113, PAT.114, PAT.115, PAT.116, PAT.119. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
While the Proteus 235 is in the pencil beam scanning (PBS) treatment mode, on rare occasions, Low Level Radio Frequency (LLRF) pulsed dee voltage (i.e., voltage applied between two electrodes in the cyclotron to accelerate protons) may generate a hot spot on a pencil beam position within a tumor, generating a dose that might exceed the prescribed dose on a single voxel.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ion Beam Applications S.A.
- Distributor
- Worldwide Distribution-USA (nationwide) including the states of PA, NJ, IL, WA, and TN, and the countries of Germany, Italy, and Czech Republic.
- Lot
- PAT.107, PAT.109, PAT.112, PAT.113, PAT.114, PAT.115, PAT.116, PAT.119.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Belgium
Related recalls
- FDAIBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PTS-10September 18, 2024
- FDAIBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment ofAugust 28, 2024
- FDAIBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment ofJune 12, 2024
- FDAIBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.May 1, 2024
- FDAGood Herbs, Inc., YUCCA, 1 oz bottle, 550 Oliver Dr Troy, MI 48084 The Quality Herb That WorksNovember 5, 2014
- FDAThe GemStar Power Supply is an accessory for the GemStar Infusion Pump. It is a two piece assembled switchingNovember 5, 2014
Questions about this recall
Was Proteus 235 Proton Therapy System for cancer treatment. recalled?
Yes. FDA published recall Z-0020-2015 on November 5, 2014. Reported hazard: While the Proteus 235 is in the pencil beam scanning (PBS) treatment mode, on rare occasions, Low Level Radio Frequency (LLRF) pulsed dee voltage (i.e., voltage applied between two electrodes in the cyclotron to accelerate protons) may generate a hot spot on a pencil beam position within a tumor, generating a dose that might exceed the prescribed dose on a single voxel.
What should I do if I have this product?
Voluntary: Firm initiated · Letter